Drugs / CD33KO-HSPC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05945849 | Feb 2024 → Feb 2029 expected | acute myeloid leukemia | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD33KO-HSPC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05945849 ↗ |
| Action | Inhibit | “so that a protein that the bone marrow stem cells usually show on their surface is not shown any more” NCT05945849 ↗ |
| Modality | Cell therapy | “CD33KO-HSPC: Stem cell transplant” NCT05945849 ↗ |